BERWYN, Pa., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's disease (PD) today announced its Founder, President and CEO was selected to participate in the 139th Yale CEO Summit in New York on December 11-12, 2023.
The Yale CEO Summit is a bi-annual event; it brings together influential CEOs from major US Fortune 500 companies for informal yet impactful collaborative dialogues. Themed "Re-imagining Your Strategic Mission with Your Current Leadership," this year's summit is set to ignite stimulating and collaborative discussions among the leaders across different industries.
"I am honored to participate in the summit and eagerly anticipate the exchange of ideas and connections with prominent leaders," said Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis.
About Annovis Bio, Inc.
Headquartered in ...